The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
FREE Daily Email Newsletter
Research Results May Aid in Treatment of Rheumatoid Arthritis
October 19, 2004 10:44 am | Product Releases | CommentsCAMBRIDGE, MA (October 18, 2004) – Researchers at Millennium Pharmaceuticals, Inc. and the
FDA Says All of Chiron’s Liverpool Flu Vaccine Output Is Unsafe
October 19, 2004 10:44 am | Product Releases | CommentsWASHINGTON, DC (October 18, 2004) – The Food & Drug Administration (FDA) said Friday that none of the influenza vaccine manufactured by Britain’s Chiron Corp. for the US market is safe for use.
FDA Revises Antidepressant Product Labeling
October 19, 2004 10:44 am | Product Releases | CommentsWASHINGTON, DC (October 18, 2004) – The Food & Drug Administration (FDA) last week directed
Apologies to NYC, But Detroit Is the City That Really Doesn’t Sleep
October 19, 2004 10:44 am | Product Releases | CommentsNEW YORK, NY (October 18, 2004) –Although New York is known as “the city that never sleeps,” a just-released study ranked Detroit as the worst city in America for shuteye. New York came in slightly better, ranking sixth on the bad-slumber list.
Consultancy Urges More Emphasis on Downstream Biopharm Processing
October 19, 2004 10:44 am | Product Releases | CommentsLONDON (October 18, 2004) – With expansion of biopharmaceuticals expected to be driven by reduced efficacy of existing drugs and a lack of treatments for new diseases, an international market consultancy has called for increased emphasis on downstream processing.
Managing Outsourced Manufacturing (2068)
October 13, 2004 7:58 am | Product Releases | CommentsReducing Risk and Lowering Costs in an Outsourced Manufacturing Model By Michael Webster, Director of Life Sciences, Ross Systems Outsourced manufacturing has exploded in the last 20 years to become a standard for companies ranging from emerging biopharmas to the global pharmaceuticals.
Codexis Names New Director of Business Development For Europe
October 12, 2004 11:28 am | Product Releases | CommentsREDWOOD CITY, CA (October 12, 2004) – Codexis, Inc. announcedthis week that Peter Ketelaar has joined the company as director of businessdevelopment, Europe.
FDA Finds Hillestad Pharmaceuticals in Violation of Permanent Injunction
October 12, 2004 11:28 am | Product Releases | CommentsWASHINGTON, DC (October 12, 2004) – The Food & Drug Administration (FDA) has informed Hillestad Pharmaceuticals, USA, Inc., of Woodruff, Wisconsin, that the firm is violating a court order prohibiting the company from using drug claims in the promotion of its dietary supplement products.
Honeywell to Acquire Aspen’s Operator Training Business
October 12, 2004 11:28 am | Product Releases | CommentsPHOENIX, AZ (October 12, 2004) – Honeywell last week announced a definitive agreement to acquire the intellectual property of the HYSYS modeling software and the Operator Training Simulation (OTS) business from Aspen Technology Inc.
Assured Automation to Distribute Memry Corp.’s ‘Firechek’ Valves
October 12, 2004 11:28 am | Product Releases | CommentsBETHEL, CT (October 12, 2004) – Memry Corp. announced last week that it has entered into an exclusive distribution agreement with Assured Automation for distribution of its Firechek valves throughout North America.
ChemBridge Corp. and University of Hong Kong In Possible...
October 12, 2004 11:28 am | Product Releases | CommentsSAN DIEGO, CA (October 12, 2004) – ChemBridge Corp. and the University of Hong Kong recently
Merck Takes Vioxx Off the Market
October 5, 2004 6:31 am | Product Releases | CommentsWASHINGTON, DC (October 4, 2004) -- The Food & Drug Administration (FDA) last week acknowledged the voluntary withdrawal from the market of Vioxx (chemicalname rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufacturedby Merck & Co.
Health Services Workers Suffer From Excessive Workloads and Stress
October 5, 2004 6:31 am | Product Releases | CommentsCHICAGO, IL (October 4, 2004) – In the health services field, wherequality of care and attention to detail are essentials, workers continue tostruggle with managing growing workloads, according to a survey released this week by CareerBuilder.com.
Cellular Genomics Appoints Klein to New Drug Development Post
October 5, 2004 6:31 am | Product Releases | CommentsBRANFORD, CT (October 4, 2004) – Cellular Genomics Inc. (CGI), a chemical genetics-based drug discovery and development company, has announced that Udo Klein, Ph.D. has joined the company in the newly created position of senior vice president of drug development Klein, who will report to Louis A.
FDA Issues Final Report on Its Regulation of Pharmaceutical
October 5, 2004 6:31 am | Product Releases | CommentsWASHINGTON, DC (October 4, 2004) – Following the second anniversary of the launch of its
